Down-regulation of Microrna-203-3p Initiates Type 2 Pathology During Schistosome Infection Via Elevation of Interleukin-33

Xing He,Jun Xie,Yange Wang,Xiaobin Fan,Qin Su,Yue Sun,Nanhang Lei,Dongmei Zhang,Guangping Gao,Weiqing Pan
DOI: https://doi.org/10.1371/journal.ppat.1006957
IF: 7.464
2018-01-01
PLoS Pathogens
Abstract:The type 2 immune response is the central mechanism of disease progression in schistosomiasis, but the signals that induce it after infection remain elusive. Aberrant microRNA (miRNA) expression is a hallmark of human diseases including schistosomiasis, and targeting the deregulated miRNA can mitigate disease outcomes. Here, we demonstrate that efficient and sustained elevation of miR-203-3p in liver tissues, using the highly hepatotropic recombinant adeno-associated virus serotype 8 (rAAV8), protects mice against lethal schistosome infection by alleviating hepatic fibrosis. We show that miR-203-3p targets interleukin-33 (IL-33), an inducer of type 2 immunity, in hepatic stellate cells to regulate the expansion and IL-13 production of hepatic group 2 innate lymphoid cells during infection. Our study highlights the potential of rAAV8-mediated miR-203-3p elevation as a therapeutic intervention for fibrotic diseases.
What problem does this paper attempt to address?